Merck touts Phase III data for antibacterial Recarbrio; Sanofi to ax 200 jobs in Japan — report
→ According to an anonymous source who reported to Reuters, French drugmaker Sanofi plans to ax 200 jobs in Japan across sales, regulatory affairs and operations. This adds to the ongoing plans of reorganization by research chief John Reed. Back in June, the company announced it would be placing 466 jobs in France and Germany on the chopping block and trimming of their staff in the US by offering employees an “early exit”. A Sanofi representative added, “Sanofi Japan plans to implement a voluntary retirement programme in order to adapt to the external environment changes and to transform our business models to continue our growth.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.